Back to results
US 2001/0027175 A1Published application
Use of certain drugs for treating nerve root injury
OwnerKjell Olmarker, Bjorn Rydevikinventors
Life of this patent
Estimating the term…
Abstract
The present invention relates to pharmaceutical compositions for the treatment of spinal disorders caused by the liberation of TNF-α comprising an effective amount of a TNF-α inhibitor, as well as a method for treatment of such disorders, and the use of TNF-α inhibitors in the preparation of pharmaceutical compositions for such treatment.
Claims2
A method for inhibiting the action of TNF-α for treating neurological conditions in a mammal by administering a TNF-α inhibitor for reducing inflammation of nerve tissue of said mammal or for reducing the injury to nerve tissue, comprising the step of:
- (A) administering a therapeutically effective dosage to said mammal of said TNF-α inhibitor wherein said TNF-α inhibitor is selected from the group consisting of etanercept and infliximab for reducing inflammation of nerve tissue of said mammal or for reducing the injury to nerve tissue.
Dependencies are inferred from the claim text.